LYCOS RETRIEVER 
Restless Leg Syndrome: Conditions
built 642 days ago
The US FDA has approved Requip� (ropinirole HCl) Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults, GlaxoSmithKline announced today. Requip is the first and only FDA-approved treatment for those patients with moderate-to-severe primary RLS, a chronic and disruptive neurological condition.
Source:
In many cases, no known cause for restless leg syndrome exists. Researchers suspect the condition may be due to an imbalance of the brain chemical dopamine. This chemical sends messages to control muscle movement.
Source:
The UK support group for RLS calls itself the "Ekbom support group" and explains that RLS and "Ekbom's Syndrome" are two names for the same condition. However, RLS and delusional parasitosis are entirely different conditions that share part of the Wittmaack-Ekbom syndrome eponym, as both syndromes were described by the same person, Karl-Axel Ekbom.[29]
Source:
Before prescribing a specific treatment, your health care provider needs to be certain you have Restless Legs Syndrome. You will likely be referred to a sleep specialist for diagnosis, and to determine whether related conditions (such as iron deficiency anemia, diabetes, arthritis or the use of anti-depressants) are contributing to the symptoms.
Source:
If you have restless legs syndrome (RLS), you are not alone. Up to 8% of the US population may have this neurological condition. RLS severely affects the lives of millions of individuals.
Source:
The medications prescribed for Restless Legs Syndrome are frequently “off-label” uses of the drugs, meaning they are not specifically intended for RLS, but have been found to help with symptoms. The dosage given for RLS is usually much less than the dosage for the intended condition.
Source:
MORE ABOUT
Conditions